All Clinical Trials - Page 12 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07732738N/ARecruiting
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
Semaglutide
- NCT07281196N/ACompleted
Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea
Semaglutide
- NCT06303284Phase 1/Phase 2Not Yet Recruiting
Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT
Teriparatide
- NCT06792422Phase 4Recruiting
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
Semaglutide
- NCT07195500N/ARecruiting
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Octreotide
- NCT07325435Phase 4Active Not Recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Semaglutide
- NCT05670379Phase 1Completed
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Semaglutide
- NCT06751589EARLY_Phase 1Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Tirzepatide
- NCT06305598Phase 1Active Not Recruiting
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Gonadorelin
- NCT07303556N/AActive Not Recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Tirzepatide
- NCT06020495Phase 3Recruiting
Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
Desmopressin
- NCT07292753N/ACompleted
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Desmopressin
- NCT06692348Phase 1Completed
A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
Orforglipron
- NCT06635629Phase 2Recruiting
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Desmopressin
- NCT07310563Phase 1Completed
A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity
Maridebart-Cafraglutide
- NCT06671587Phase 4Recruiting
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
Lixisenatide
- NCT06662539Phase 2Completed
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Petrelintide
- NCT06704763Phase 1Completed
A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
Orforglipron
- NCT06382948Phase 3Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Gonadorelin
- NCT06700538Phase 1/Phase 2Recruiting
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Tirzepatide
- NCT06648031Phase 1Completed
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Tirzepatide
- NCT06719011Phase 1Completed
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Cagrilintide
- NCT06717698Phase 2Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Semaglutide
- NCT06716307Phase 1Completed
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Semaglutide
- NCT06821100Phase 1Recruiting
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Thymosin-Alpha-1
- NCT06881628Phase 4Recruiting
Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients
Octreotide
- NCT06803199N/ARecruiting
Effects of LH and FSH on Metabolic Regulation in Cumulus Cells
Gonadorelin
- NCT07199894Phase 3Recruiting
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Desmopressin
- NCT06716216Phase 3Recruiting
A Study of BGM0504 in Participants with Type 2 Diabetes
Semaglutide
- NCT06517212Phase 2Recruiting
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Tirzepatide
- NCT06523530Phase 4Active Not Recruiting
Effect of a GnRH Analog on Hepatic Steatosis
Gonadorelin
- NCT07717814Phase 1Completed
A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity
Maridebart-Cafraglutide
- NCT07370922Phase 2Completed
Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
Dulaglutide
- NCT06191848Phase 4Recruiting
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
Tirzepatide
- NCT06672549Phase 3Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Orforglipron
- NCT06672939Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Orforglipron
- NCT06761703N/ACompleted
A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
Tirzepatide
- NCT06632457Phase 3Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Survodutide
- NCT06531499Phase 1Recruiting
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
Gonadorelin
- NCT06246799Phase 3Recruiting
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Tirzepatide
- NCT06660173Phase 2Active Not Recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Maridebart-Cafraglutide
- NCT06534411Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Tirzepatide
- NCT06662383Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Retatrutide
- NCT06779929N/ACompleted
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Tirzepatide
- NCT06467604N/AActive Not Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
Tirzepatide
- NCT07092605EARLY_Phase 1Enrolling By Invitation
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Semaglutide
- NCT06771128N/ACompleted
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06649344Phase 3Completed
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
Semaglutide
- NCT06518837Phase 2Recruiting
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Tirzepatide
- NCT06162715Phase 2/Phase 3Active Not Recruiting
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Tirzepatide